학술논문

Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease.
Document Type
Article
Source
Molecular Oncology; Jun2023, Vol. 17 Issue 6, p1129-1147, 19p
Subject
Language
ISSN
15747891